<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="methods-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2017.01100</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Microbiology</subject>
<subj-group>
<subject>Methods</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Algevir: An Expression System for Microalgae Based on Viral Vectors</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ba&#x000F1;uelos-Hern&#x000E1;ndez</surname> <given-names>Bernardo</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn001"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/264349/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Monreal-Escalante</surname> <given-names>Elizabeth</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/440718/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Gonz&#x000E1;lez-Ortega</surname> <given-names>Omar</given-names></name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Angulo</surname> <given-names>Carlos</given-names></name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/418993/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Rosales-Mendoza</surname> <given-names>Sergio</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn002"><sup>&#x0002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/201738/overview"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratorio de Biofarmac&#x000E9;uticos recombinantes, Facultad de Ciencias Qu&#x000ED;micas, Universidad Aut&#x000F3;noma de San Luis Potos&#x000ED;</institution> <country>San Luis Potos&#x000ED;, Mexico</country></aff>
<aff id="aff2"><sup>2</sup><institution>Secci&#x000F3;n de Biotecnolog&#x000ED;a, Centro de Investigaci&#x000F3;n en Ciencias de la Salud y Biomedicina, Universidad Aut&#x000F3;noma de San Luis Potos&#x000ED;</institution> <country>San Luis Potos&#x000ED;, Mexico</country></aff>
<aff id="aff3"><sup>3</sup><institution>Laboratorio de Bioseparaciones, Facultad de Ciencias Qu&#x000ED;micas, Universidad Aut&#x000F3;noma de San Luis Potos&#x000ED;</institution> <country>San Luis Potos&#x000ED;, Mexico</country></aff>
<aff id="aff4"><sup>4</sup><institution>Grupo de Inmunolog&#x000ED;a &#x00026; Vacunolog&#x000ED;a. Centro de Investigaciones Biol&#x000F3;gicas del Noroeste, SC., Instituto Polit&#x000E9;cnico Nacional 195</institution> <country>La Paz, Mexico</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Robert Kourist, Graz University of Technology, Austria</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Anne Sawyer, Ruhr University Bochum, Germany; Jiangxin Wang, Shenzhen University, China</p></fn>
<fn fn-type="corresp" id="fn001"><p>&#x0002A;Correspondence: Bernardo Ba&#x000F1;uelos-Hern&#x000E1;ndez <email>berbanher&#x00040;gmail.com</email></p></fn>
<fn fn-type="corresp" id="fn002"><p>Sergio Rosales-Mendoza <email>rosales.s&#x00040;fcq.uaslp.mx</email></p></fn>
<fn fn-type="other" id="fn003"><p>This article was submitted to Microbiotechnology, Ecotoxicology and Bioremediation, a section of the journal Frontiers in Microbiology</p></fn></author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>06</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>1100</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>03</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>31</day>
<month>05</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Ba&#x000F1;uelos-Hern&#x000E1;ndez, Monreal-Escalante, Gonz&#x000E1;lez-Ortega, Angulo and Rosales-Mendoza.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Ba&#x000F1;uelos-Hern&#x000E1;ndez, Monreal-Escalante, Gonz&#x000E1;lez-Ortega, Angulo and Rosales-Mendoza</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>The use of recombinant algae for the production of valuable compounds is opening promising biotechnological applications. However, the development of efficient expression approaches is still needed to expand the exploitation of microalgae in biotechnology. Herein, the concept of using viral expression vectors in microalgae was explored for the first time. An inducible geminiviral vector leading to Rep-mediated replication of the expression cassette allowed the production of antigenic proteins at high levels. This system, called Algevir, allows the production of complex viral proteins (GP1 from <italic>Zaire ebolavirus</italic>) and bacterial toxin subunits (B subunit of the heat-labile <italic>Escherichia coli</italic> enterotoxin), which retained their antigenic activity. The highest achieved yield was 1.25 mg/g fresh biomass (6 mg/L of culture), which was attained 3 days after transformation. The Algevir system allows for a fast and efficient production of recombinant proteins, overcoming the difficulties imposed by the low yields and unstable expression patterns frequently observed in stably transformed microalgae at the nuclear level; as well as the toxicity of some target proteins.</p>
</abstract>
<kwd-group>
<kwd><italic>Schizochytrium</italic> sp.</kwd>
<kwd>marine microalgae</kwd>
<kwd>vaccine</kwd>
<kwd>replicon</kwd>
<kwd>viral elements</kwd>
<kwd>geminivirus</kwd>
<kwd>recombinant protein yield</kwd>
<kwd>transient expression</kwd>
</kwd-group>
<contract-num rid="cn001">INFR-2016-271182</contract-num>
<contract-num rid="cn001">CB-256063</contract-num>
<contract-num rid="cn001">PDCPN2014-01/248033</contract-num>
<contract-sponsor id="cn001">Consejo Nacional de Ciencia y Tecnolog&#x000ED;a<named-content content-type="fundref-id">10.13039/501100003141</named-content></contract-sponsor>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="28"/>
<page-count count="6"/>
<word-count count="4181"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="s1">
<title>Introduction</title>
<p>The use of microalgae for the production of valuable proteins is acquiring relevance in the biotechnology field. Several functional vaccine antigens, antibodies, and other therapeutic proteins; as well as enzymes for industrial use, have been produced in microalgae (Scranton et al., <xref ref-type="bibr" rid="B24">2015</xref>; Rosales-Mendoza, <xref ref-type="bibr" rid="B21">2016a</xref>). The highest yields, observed thus far, were achieved in photosynthetic microalgae transformed at the chloroplast genome; with yields up to 3 mg/L culture (1.86% of Total Soluble Protein (TSP); Gimpel et al., <xref ref-type="bibr" rid="B7">2015</xref>). Nonetheless, the development of transplastomic clones requires laborious construction of species-specific vectors and the system is unable to carry out complex post-translational modifications (e.g., glycosylation) or secrete the recombinant protein. In the case of nuclear expression, genetic engineering faces two challenges: the improvement of yields and the genetic stability of the transformed clones (Rosales-Mendoza, <xref ref-type="bibr" rid="B22">2016b</xref>). In an effort to overcome these obstacles, UV mutagenesis has been used to generate <italic>Chlamydomonas reinhardtii</italic> strains with improved transgene expression (showing yields up to 0.2% TSP; Neupert et al., <xref ref-type="bibr" rid="B15">2009</xref>; Kurniasih et al., <xref ref-type="bibr" rid="B11">2016</xref>). Secretion approaches have also been implemented in these mutant strains, leading to yields up to 10 mg of secreted reporter protein per liter of culture (Lauersen et al., <xref ref-type="bibr" rid="B12">2013</xref>).</p>
<p>Viral vectors have been widely applied in the expression of heterologous proteins in plants (Gleba et al., <xref ref-type="bibr" rid="B9">2007</xref>; Lico et al., <xref ref-type="bibr" rid="B13">2008</xref>; Chen et al., <xref ref-type="bibr" rid="B4">2011</xref>; Dugdale et al., <xref ref-type="bibr" rid="B6">2013</xref>; Salazar-Gonz&#x000E1;lez et al., <xref ref-type="bibr" rid="B23">2015</xref>). For instance, the Magnifection system described 10 years ago became a powerful tool for the expression of recombinant proteins in higher plants via transient expression (Gleba et al., <xref ref-type="bibr" rid="B8">2005</xref>, <xref ref-type="bibr" rid="B10">2013</xref>; Marillonnet et al., <xref ref-type="bibr" rid="B14">2005</xref>). In the case of microalgae, some viral elements have been used to innovate genetic engineering approaches. For instance, the picornaviral 2A sequence has allowed the expression of polycistrons (Rasala et al., <xref ref-type="bibr" rid="B19">2012</xref>) while synthetic promoters have led to improved expression (Scranton et al., <xref ref-type="bibr" rid="B25">2016</xref>). Surprisingly, the use of viral vectors has not been explored in algal biotechnology thus far. Herein the expression of biopharmaceuticals using a geminiviral vector was explored in the marine microalga <italic>Schizochytrium</italic> sp., which is an attractive species due to its ability to grow heterotrophically in marine water; thus not depending on photobioreactors. We used two antigen models for viral (glycoprotein 1, GP1, from <italic>Zaire ebolavirus</italic>) and bacterial (the B subunit of <italic>Escherichia coli</italic> heat-labile enterotoxin, LTB) diseases, which have high impact on the public health of developing countries. The viral vector-based expression system was functional and led to efficient expression of biopharmaceuticals.</p>
</sec>
<sec sec-type="materials and methods" id="s2">
<title>Materials and methods</title>
<sec>
<title>Vector design</title>
<p>An inducible vector was designed using the following elements: the <italic>AlcR</italic> gene and <italic>AlcA</italic> promoter from <italic>Aspergillus nidulans</italic>, the replication protein &#x0201C;Rep,&#x0201D; and the origin of replication &#x0201C;Ori&#x0201D; from the geminivirus <italic>Ageratum enation virus</italic>. The elements of the viral vector were placed in the following order: <italic>Cauliflower mosaic virus 35S</italic> promoter, <italic>AlcR</italic> gene, nopaline synthase terminator (nos), Ori, <italic>AlcA</italic> promoter, <italic>Sma</italic> I, <italic>Bam</italic>HI, and <italic>Pst</italic> I restriction sites, 35S terminator, Ori (repeated), <italic>AlcA</italic> promoter, and Rep protein ORF. A DNA fragment containing this array was synthetized by GenScript Inc. (New Jersey, USA) and sub-cloned in the binary vector pBI121 at the <italic>Xba</italic>I-<italic>Sac</italic> I sites through standard digestion-ligation procedures. A positive clone identified by restriction profile was used to perform sequencing and confirm sequence integrity; the construct was subsequently transferred into <italic>Agrobacterium tumefaciens</italic> (GV3101 strain) by electroporation (Cangelosi et al., <xref ref-type="bibr" rid="B3">1991</xref>). A clone carrying the expression vector was confirmed by PCR and subsequently cultivated overnight in Luria Bertani broth at 25&#x000B0;C and 200 rpm to perform expression experiments.</p>
</sec>
<sec>
<title>Microalga transient transformation</title>
<p>The <italic>Schizochytrium</italic> sp. strain 20888 was obtained from ATCC (USA), it was cultured at 25&#x000B0;C in modified seawater medium (5 g/L peptone, 1 g/L yeast extract, 0.2 g/L FeSO<sub>4</sub>, 15 g/L agar, and 35 g/L NaCl). For liquid cultures, the 679BY medium was used (1 g/L yeast extract, 1 g/L peptone, 5 g/L dextrose, and 35 g/L NaCl). Cultures were incubated at 150 rpm. Transformation was carried out by inoculating <italic>Schizochytrium</italic> sp. cultures (100 mL, OD<sub>650nm</sub> &#x0003D; 0.7) with 1 mL of <italic>A. tumefaciens</italic> culture (OD<sub>650nm</sub> &#x0003D; 1.0). The medium was supplemented with 100 &#x003BC;M acetosyringone. 16 h post-inoculation cefotaxime was added at a final concentration of 250 mg/L. The expression of the gene of interest in the transiently transformed microalgae was induced 20 h post-inoculation by the addition of 1 mL of absolute ethanol (1% of final concentration). Culture samples were collected before induction and 12, 24, and 48 h post-induction. Samples were stored at &#x02212;80&#x000B0;C until further use.</p>
</sec>
<sec>
<title>Inverse PCR</title>
<p>Circular DNA replicons were detected by inverse PCR using the following primer sets: for GP1, forward 5&#x02032;CATCACCAAGATACCGGAGAAG and reverse 5&#x02032;TTTAGTTTCCCAGAAGGCCC3&#x02032;; for LTB, forward 5&#x02032;CATTTCCCTCTTTCCAGCCAand reverse 5&#x02032;TTATGGAGAAACTCGAGCTTGT 3&#x02032;. Total DNA was isolated from <italic>Schizochytrium</italic> sp. cultures according to Dellaporta et al. (<xref ref-type="bibr" rid="B5">1983</xref>). PCR reaction mixtures (25 &#x003BC;L) contained 1 &#x000D7; PCR buffer, 100 ng DNA, 1.5 mM magnesium chloride, 2.5 U Taq DNA polymerase, 1 mM dNTPs, and 1 &#x003BC;M of the corresponding primer set. Cycling conditions were: 94&#x000B0;C for 5 min (initial denaturation); 35 cycles at 94&#x000B0;C for 30 s, 55&#x000B0;C for 30 s, 72&#x000B0;C for 120 s, and a final extension at 72&#x000B0;C for 10 min. PCR products were detected by electrophoresis in 1% agarose gels. The negative control consisted of 100 ng of DNA from WT <italic>Schizochytrium</italic> sp. culture.</p>
</sec>
<sec>
<title>Protein analysis</title>
<p>The integrity of the <italic>Schizochytrium</italic>-made recombinant proteins was assessed by Western blot analysis. Culture samples were collected at different post-induction times (0, 12, 24, and 48 h) and protein extracts were obtained as follows: 20 mg of fresh biomass were resuspended in 200 &#x003BC;L of extraction buffer (750 mM Tris-HCl, pH 8, 15% sucrose, 100 mM &#x003B2;-mercaptoethanol, and 1 mM PMSF) and sonicated (4 pulses of 4 s with a 4 s delay in between) using an ultrasonic processor equipment at 24% amplitude (model GEX130PB). Samples were subsequently centrifuged at 8,000 rpm for 15 min and the supernatants were transferred to new microtubes. Total soluble protein concentration was determined in the extracts by the Lowry method and a volume corresponding to 80 &#x003BC;g of TSP (approximately 100 &#x003BC;L) was mixed with the same volume of 2 &#x000D7; reducing loading buffer, denatured by boiling for 5 min at 95&#x000B0;C, and subsequently subjected to SDS-PAGE analysis. Gels were blotted onto 0.45 &#x003BC;m Bio-Rad nitrocellulose membranes (<ext-link ext-link-type="uri" xlink:href="http://www.bio-rad.com">http://www.bio-rad.com</ext-link>). Protein transfer was performed using a TV100-EBK Electroblotter (AlphaMetrix Biotech, GER) for 1 h at 150 V in a methanol-based transfer buffer. After blocking with 5% fat-free milk (Carnation, Nestle) dissolved in PBS-0.1% Tween, the blots were incubated with mouse anti-sera (1:200 dilution) against either LTB or GP1; which were produced in mice as previously described (Orellana-Escobedo et al., <xref ref-type="bibr" rid="B16">2015</xref>). The blots were washed and incubated with a goat horseradish peroxidase-conjugated secondary anti-IgG mouse antibody (1:2,000 dilution, Sigma) for 2 h at room temperature. Antigen detection was revealed by incubating blots with the SuperSignal West Dura solution following the instructions from the manufacturer (Thermo Scientific, <ext-link ext-link-type="uri" xlink:href="http://www.thermoscientific.com">http://www.thermoscientific.com</ext-link>) and exposing the film to standard procedures. LTB and GP1 proteins (250 ng) purified from recombinant <italic>E. coli</italic> were used as positive controls.</p>
<p>For quantitative ELISA, a protocol described elsewhere was applied (R&#x000ED;os-Huerta et al., <xref ref-type="bibr" rid="B20">2017</xref>). Briefly, protein extracts were obtained as described above and diluted with 0.2 M carbonate buffer (pH &#x0003D; 9.6). The diluted sample was added to an ELISA plate for protein adsorption at 4&#x000B0;C. After blocking with 5% fat-free dry milk solution for 2 h at room temperature, the plates were incubated with either anti-LTB (1:500 dilution) or anti-GP1 mouse serum (1:1,000 dilution) overnight at 4&#x000B0;C. The plates were subsequently incubated with a rabbit horseradish peroxidase-conjugated anti-mouse IgG (1:2,000 dilution) for 2 h at 25&#x000B0;C. A colorimetric reaction was induced by addition of the ABTS substrate solution (0.6 mM 2,2&#x02032;-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid), 0.1 M citric acid, pH &#x0003D; 4.35, and 1 mM H<sub>2</sub>O<sub>2</sub>), after 30 min of incubation at 25&#x000B0;C OD values were measured at 405 nm. Standard curves were constructed using pure LTB or GP1 to estimate expression levels.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec>
<title>The pAlgevir vector is delivered and replicated in microalgae</title>
<p>Gene synthesis and molecular cloning techniques allowed the construction of the pAlgevir vector; whose physical map is shown in Figure <xref ref-type="fig" rid="F1">1</xref> while the restriction profile and sequence are shown in Figures S1, S2, respectively. The <italic>AlcR</italic> gene from <italic>A. nidulans</italic> is under the control of the <italic>Cauliflower mosaic virus 35S</italic> promoter and the nos terminator, whereas the Rep protein is under the control of the <italic>AlcA</italic> inducible promoter from <italic>A. nidulans</italic> and the nos terminator. The gene of interest, which is inserted into the <italic>Sma</italic>I at the 5&#x02032; end and either <italic>Bam</italic>HI or <italic>Pst</italic>I sites at the 3&#x02032; end, is under the control of the inducible <italic>AlcA</italic> promoter and the 35S terminator. Upon ethanol induction, the transcription factor AlcR is activated leading to the expression of the gene of interest and the Rep protein. The latter acts on the Ori elements and mediates the generation and replication of circular DNA molecules carrying the expression cassette for the biopharmaceutical. The obtained restriction profile for the pAlgevir vector is shown in Figure <xref ref-type="supplementary-material" rid="SM1">S1</xref>.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>Physical map of the pAlgevir vector. The vector mediates the ethanol-inducible expression of the target protein through the AlcR transcription factor, which is constitutively expressed under the control of the <italic>Cauliflower mosaic virus 35S</italic> promoter and upon ethanol presence activates the <italic>AlcA</italic> promoter. The <italic>AlcA</italic> promoter and AlcR belong to <italic>Aspergillus nidulans</italic>. The Rep protein leads to replication of the expression cassette flanked by Ori elements.</p></caption>
<graphic xlink:href="fmicb-08-01100-g0001.tif"/>
</fig>
</sec>
<sec>
<title>Algevir allows efficient expression of viral and bacterial antigens</title>
<p>Expression studies were conducted to evaluate the efficiency of the Algevir system. <italic>Schizochytrium</italic> sp. cultures were inoculated with recombinant agrobacteria and induced with ethanol 20 h post-inoculation, with the subsequent analysis to determine vector replication and recombinant protein yields at different post-induction times. We first investigated the presence of DNA replicons through inverse PCR analysis to prove the expression of functional Rep leading to replication of the expression cassette. In this approach PCR primers landing in the expression cassette flanks but at a divergent position allow the amplification of circular molecules only, which are generated by rolling circle replication; whereas lineal forms of the expression cassette are not amplified. Transformed and induced <italic>Schizochytrium</italic> sp. cultures showed a positive result at any studied time point, indicating that the Algevir plasmid mediates the generation of replicons by rolling circle replication (Figure <xref ref-type="fig" rid="F2">2</xref>). The amplification was also detected at the pre-induction phase, which suggested a basal transcription of the Rep protein before ethanol induction. In terms of recombinant protein production, <italic>Schizochytrium</italic> sp. showed a minimum level of recombinant protein at the pre-induction phase. The recombinant protein levels dramatically increased upon induction, reaching the highest levels 48 h post-induction (Figure <xref ref-type="fig" rid="F3">3</xref>). According to an ELISA, the recombinant protein yields 48 h post-induction reached values up to 1.25 mg/g fresh weight (FW) for GP1 (6 mg/L of culture) and 0.12 mg/g FW (0.6 mg/L of culture) for LTB (Figure <xref ref-type="fig" rid="F4">4</xref>). Quantitative ELISA analysis confirmed that 48 h post-induction was the time point with maximum yields whereas shorter or extended post-induction times showed significantly lower protein yields (data not shown).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>Detection of replicons by inverse PCR. Total DNA samples from <italic>Schizochrytrium</italic> sp. transiently transformed with pAlgevir-GP1 <bold>(A)</bold> and pAlgevir-LTB <bold>(B)</bold> vectors were analyzed by PCR using primers to detect circular replicons generated by Rep. Lanes: M, 1 Kb ladder (New England, biolabs); 1&#x02013;5, DNA samples from <italic>Schizochrytrium</italic> sp. cultures transiently transformed with <italic>A. tumefaciens</italic> carrying the corresponding pAlgevir vector at 0, 12, 24, 48, and 72 h post-induction, respectively; 6: DNA sample from wild type <italic>Schizochrytrium</italic> sp. culture; 7, negative control (water). Expected amplicons for the detection of GP1 and LTB replicons are 1,800 and 918 bp in length, respectively.</p></caption>
<graphic xlink:href="fmicb-08-01100-g0002.tif"/>
</fig>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>Immunodetection of the GP1 and LTB recombinant proteins produced in <italic>Shizochrytrium</italic> sp. through the Algevir system. <italic>Schizochrytrium</italic> sp. cultures were transiently transformed with <italic>A. tumefaciens</italic> carrying the pAlgevir vector. Total soluble proteins were extracted and subjected to Western blot analysis labeling with anti-sera against GP1 <bold>(A)</bold> or LTB <bold>(B)</bold>. Positive controls consisted of 250 ng of either GP1 or LTB.</p></caption>
<graphic xlink:href="fmicb-08-01100-g0003.tif"/>
</fig>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>Yields of the recombinant proteins produced in <italic>Shizochrytrium</italic> sp. with the Algevir system. Quantitative ELISA was performed to determine the accumulation levels of the <italic>Shizochrytrium</italic> sp.-made proteins 48 h post-induction. Pure proteins were used to construct standard curves for GP1 <bold>(A)</bold> and LTB <bold>(B)</bold>. Accumulation levels are expressed as milligrams of recombinant protein per gram of fresh microalgae biomass or milligrams of recombinant protein per liter of microalgae culture <bold>(C)</bold>. The presented values are the means of triplicates &#x000B1; standard deviation.</p></caption>
<graphic xlink:href="fmicb-08-01100-g0004.tif"/>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>The use of viral vectors to produce recombinant proteins in algae has not been explored thus far. Herein, the Algevir system was developed as an attractive approach for the transient expression of recombinant proteins in microalgae using the replication elements from the begomovirus <italic>Ageratum enation virus</italic>. For the design of the Algevir vector we adopted an inducible vector comprising the <italic>AlcA</italic> promoter, which has a fungal origin and it is induced by ethanol in a mechanism mediated by the AlcR protein.</p>
<p>To assess the potential of the Algevir system we selected two relevant biopharmaceuticals: GP1 from <italic>Z. ebolavirus</italic>, which is a complex viral glycoprotein implicated in the development of subunit vaccines against Ebola since it induces neutralizing humoral responses (Sridhar, <xref ref-type="bibr" rid="B27">2015</xref>); and a bacterial antigen with relevance in vaccination against enteric diseases (Zhang and Sack, <xref ref-type="bibr" rid="B28">2015</xref>). These antigenic proteins were successfully expressed in <italic>Schizochytrium</italic> sp., revealing a robust capacity of the Algevir system for the expression of both bacterial and complex viral glycoproteins that retained their antigenicity. The maximum expression levels were attained for GP1 2 days post-induction, reaching a maximum value of 6 mg/L. Under our conditions the protein yields decreased at 72 h post-induction, since replicons are still detected at this time point; this decrease is most likely due to a lower transcriptional activity associated to a decrement in ethanol levels.</p>
<p>In the field of biopharmaceuticals production using recombinant algae, the most productive systems for expressing heterologous proteins comprise the following: (i) Yields up to 3 mg/L were achieved by Gimpel et al. (<xref ref-type="bibr" rid="B7">2015</xref>) for the Bovine Milk Amyloid A protein following a chloroplast expression approach. Nonetheless, chloroplast expression restricts the system to proteins not requiring glycosylation (no evidence has been reported on these post-translational modifications occurring in the chloroplast of microalgae). (ii) The recently reported nuclear expression approaches led to yields up to 15 mg/L under the modality of recombinant protein secretion to the culture medium, using either synthetic glycomodules (tandem serine and proline repeats) that improve secretion or a mutant strain that efficiently expresses heterologous genes (Lauersen et al., <xref ref-type="bibr" rid="B12">2013</xref>; Ramos-Martinez et al., <xref ref-type="bibr" rid="B18">2017</xref>). However, these yields correspond to evaluations using reporter genes and not complex biopharmaceuticals. (iii) Recombinant hemagglutinin proteins from the influenza virus were expressed in the microalga <italic>Schizochytrium</italic> sp. in a secretion modality reaching yields up to 20 mg/L. It should be considered that this system is conceived for the production of parenteral vaccines through purification of the antigen from culture supernatants (Bayne et al., <xref ref-type="bibr" rid="B1">2013</xref>).</p>
<p>When compared to the previous systems, the Algevir system is considered attractive since it possesses features that overcome some of the limitations showed by the existing expression approaches. First, nuclear expression allows accessing complex cellular machinery to perform glycosylation and other post-translational modifications. In contrast to secretion approaches, the intracellular accumulation of the antigens allows using the whole cell as vaccine delivery vehicle; which is relevant since it can serve as a biocapsule. For instance, <italic>Schizochytrium</italic> sp. produces several endogenous compounds that could exert immunomodulatory effects such as polyunsaturated fatty acids (Bragaglio et al., <xref ref-type="bibr" rid="B2">2015</xref>). Second, Algevir is based on the inducible expression of the target protein, which offers short production times (1 week at the most) and the particular advantage of allowing the expression of proteins exerting toxic effects in the host since biomass production is dissociated from the recombinant protein expression phase. Third, since Algevir is based on transient expression; the problems related to the generation of stable transformants that are prone to genetic instability are avoided (Rosales-Mendoza, <xref ref-type="bibr" rid="B22">2016b</xref>). Therefore, Algevir is a versatile system offering the advantages of transient expression (short production time and high yields) that are ideal for the production of vaccines in response to epidemics.</p>
<p>The Algevir system was initially tested with the marine microalgae <italic>Schizochytrium</italic> sp., which is grown heterotrophycally and currently produced at an industrial scale; thus the adoption and scale-up of this technology will be greatly facilitated (Qu et al., <xref ref-type="bibr" rid="B17">2013</xref>; Song et al., <xref ref-type="bibr" rid="B26">2015</xref>). In conclusion, the Algevir system is a robust approach for producing recombinant proteins in microalgae that will open a new path in algal biotechnology.</p>
</sec>
<sec id="s5">
<title>Author contributions</title>
<p>BB performed most of the experiments. BB and SR carried out the experimental design, data analysis and wrote the manuscript. EM conducted protein detection analysis. CA and OG contributed to the data analysis. All authors discussed the results, read and approved the final version of the manuscript.</p>
<sec>
<title>Conflict of interest statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The work presented in this report is the subject of a pending patent.</p>
</sec>
</sec>
</body>
<back>
<ack><p>We acknowledge Jesus Gutierrez-Canela for helping with propagation and preservation of the studied strains.</p>
</ack>
<sec sec-type="supplementary-material" id="s6">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="http://journal.frontiersin.org/article/10.3389/fmicb.2017.01100/full#supplementary-material">http://journal.frontiersin.org/article/10.3389/fmicb.2017.01100/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bayne</surname> <given-names>A. C.</given-names></name> <name><surname>Boltz</surname> <given-names>D.</given-names></name> <name><surname>Owen</surname> <given-names>C.</given-names></name> <name><surname>Betz</surname> <given-names>Y.</given-names></name> <name><surname>Maia</surname> <given-names>G.</given-names></name> <name><surname>Azadi</surname> <given-names>P.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Vaccination against influenza with recombinant hemagglutinin expressed by <italic>Schizochytrium</italic> sp. confers protective immunity</article-title>. <source>PLoS ONE</source> <volume>8</volume>:<fpage>e61790</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0061790</pub-id><pub-id pub-id-type="pmid">23626728</pub-id></citation></ref>
<ref id="B2">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bragaglio</surname> <given-names>A.</given-names></name> <name><surname>Braghieri</surname> <given-names>A.</given-names></name> <name><surname>Napolitano</surname> <given-names>F.</given-names></name> <name><surname>De Rosa</surname> <given-names>G.</given-names></name> <name><surname>Riviezzi</surname> <given-names>A. M.</given-names></name> <name><surname>Surianello</surname> <given-names>F.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>Omega-3 supplementation, milk quality and cow immune-competence</article-title>. <source>Italian J. Agron.</source> <volume>10</volume>, <fpage>9</fpage>&#x02013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.4081/ija.2015.611</pub-id></citation></ref>
<ref id="B3">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cangelosi</surname> <given-names>G. A.</given-names></name> <name><surname>Best</surname> <given-names>E. A.</given-names></name> <name><surname>Martinetti</surname> <given-names>G.</given-names></name> <name><surname>Nester</surname> <given-names>E. W.</given-names></name></person-group> (<year>1991</year>). <article-title>Genetic analysis of Agrobacterium</article-title>. <source>Meth. Enzymol.</source> <volume>204</volume>, <fpage>384</fpage>&#x02013;<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1016/0076-6879(91)04020-O</pub-id><pub-id pub-id-type="pmid">1658565</pub-id></citation></ref>
<ref id="B4">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Q.</given-names></name> <name><surname>He</surname> <given-names>J.</given-names></name> <name><surname>Phoolcharoen</surname> <given-names>W.</given-names></name> <name><surname>Mason</surname> <given-names>H. S.</given-names></name></person-group> (<year>2011</year>). <article-title>Geminiviral vectors based on bean yellow dwarf virus for production of vaccine antigens and monoclonal antibodies in plants</article-title>. <source>Hum. Vaccin.</source> <volume>7</volume>, <fpage>331</fpage>&#x02013;<lpage>338</lpage>. <pub-id pub-id-type="doi">10.4161/hv.7.3.14262</pub-id><pub-id pub-id-type="pmid">21358270</pub-id></citation></ref>
<ref id="B5">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dellaporta</surname> <given-names>S. L.</given-names></name> <name><surname>Wood</surname> <given-names>J.</given-names></name> <name><surname>Hicks</surname> <given-names>J. B.</given-names></name></person-group> (<year>1983</year>). <article-title>A plant DNA minipreparation: Version II</article-title>. <source>Plant Mol. Biol. Rep.</source> <volume>1</volume>, <fpage>19</fpage>&#x02013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1007/BF02712670</pub-id></citation></ref>
<ref id="B6">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dugdale</surname> <given-names>B.</given-names></name> <name><surname>Mortimer</surname> <given-names>C. L.</given-names></name> <name><surname>Kato</surname> <given-names>M.</given-names></name> <name><surname>James</surname> <given-names>T. A.</given-names></name> <name><surname>Harding</surname> <given-names>R. M.</given-names></name> <name><surname>Dale</surname> <given-names>J. L.</given-names></name></person-group> (<year>2013</year>). <article-title>In plant activation: an inducible, hyperexpression platform for recombinant protein production in plants</article-title>. <source>Plant Cell</source> <volume>25</volume>, <fpage>2429</fpage>&#x02013;<lpage>2443</lpage>. <pub-id pub-id-type="doi">10.1105/tpc.113.113944</pub-id><pub-id pub-id-type="pmid">23839786</pub-id></citation></ref>
<ref id="B7">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gimpel</surname> <given-names>J. A.</given-names></name> <name><surname>Hyun</surname> <given-names>J. S.</given-names></name> <name><surname>Schoepp</surname> <given-names>N. G.</given-names></name> <name><surname>Mayfield</surname> <given-names>S. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Production of recombinant proteins in microalgae at pilot greenhouse scale</article-title>. <source>Biotechnol. Bioeng.</source> <volume>112</volume>, <fpage>339</fpage>&#x02013;<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1002/bit.25357</pub-id><pub-id pub-id-type="pmid">25116083</pub-id></citation></ref>
<ref id="B8">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gleba</surname> <given-names>Y.</given-names></name> <name><surname>Klimyuk</surname> <given-names>V.</given-names></name> <name><surname>Marillonnet</surname> <given-names>S.</given-names></name></person-group> (<year>2005</year>). <article-title>Magnifection&#x02014;a new platform for expressing recombinant vaccines in plants</article-title>. <source>Vaccine</source> <volume>23</volume>, <fpage>2042</fpage>&#x02013;<lpage>2048</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2005.01.006</pub-id><pub-id pub-id-type="pmid">15755568</pub-id></citation></ref>
<ref id="B9">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gleba</surname> <given-names>Y.</given-names></name> <name><surname>Klimyuk</surname> <given-names>V.</given-names></name> <name><surname>Marillonnet</surname> <given-names>S.</given-names></name></person-group> (<year>2007</year>). <article-title>Viral vectors for the expression of proteins in plants</article-title>. <source>Curr. Opin. Biotechnol.</source> <volume>18</volume>, <fpage>134</fpage>&#x02013;<lpage>141</lpage>. <pub-id pub-id-type="doi">10.1016/j.copbio.2007.03.002</pub-id><pub-id pub-id-type="pmid">17368018</pub-id></citation></ref>
<ref id="B10">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Gleba</surname> <given-names>Y.</given-names></name> <name><surname>Tus&#x000E9;</surname> <given-names>D.</given-names></name> <name><surname>Giritch</surname> <given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Plant viral vectors for delivery by Agrobacterium</article-title>, in <source>Plant Viral Vectors</source>, eds <person-group person-group-type="editor"><name><surname>Palmer</surname> <given-names>K.</given-names></name> <name><surname>Gleba</surname> <given-names>Y.</given-names></name></person-group> (<publisher-loc>Berlin; Heidelberg</publisher-loc>: <publisher-name>Springer</publisher-name>), <fpage>155</fpage>&#x02013;<lpage>192</lpage>.</citation></ref>
<ref id="B11">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kurniasih</surname> <given-names>S. D.</given-names></name> <name><surname>Yamasaki</surname> <given-names>T.</given-names></name> <name><surname>Kong</surname> <given-names>F.</given-names></name> <name><surname>Okada</surname> <given-names>S.</given-names></name> <name><surname>Widyaningrum</surname> <given-names>D.</given-names></name> <name><surname>Ohama</surname> <given-names>T.</given-names></name></person-group> (<year>2016</year>). <article-title>UV-mediated Chlamydomonas mutants with enhanced nuclear transgene expression by disruption of DNA methylation-dependent and independent silencing systems</article-title>. <source>Plant Mol. Biol.</source> <volume>92</volume>, <fpage>629</fpage>&#x02013;<lpage>641</lpage>. <pub-id pub-id-type="doi">10.1007/s11103-016-0529-9</pub-id><pub-id pub-id-type="pmid">27761764</pub-id></citation></ref>
<ref id="B12">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauersen</surname> <given-names>K. J.</given-names></name> <name><surname>Berger</surname> <given-names>H.</given-names></name> <name><surname>Mussgnug</surname> <given-names>J. H.</given-names></name> <name><surname>Kruse</surname> <given-names>O.</given-names></name></person-group> (<year>2013</year>). <article-title>Efficient recombinant protein production and secretion from nuclear transgenes in <italic>Chlamydomonas reinhardtii</italic></article-title>. <source>J. Biotechnol.</source> <volume>167</volume>, <fpage>101</fpage>&#x02013;<lpage>110</lpage>. <pub-id pub-id-type="doi">10.1016/j.jbiotec.2012.10.010</pub-id><pub-id pub-id-type="pmid">23099045</pub-id></citation></ref>
<ref id="B13">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lico</surname> <given-names>C.</given-names></name> <name><surname>Chen</surname> <given-names>Q.</given-names></name> <name><surname>Santi</surname> <given-names>L.</given-names></name></person-group> (<year>2008</year>). <article-title>Viral vectors for production of recombinant proteins in plants</article-title>. <source>J. Cell Physiol.</source> <volume>216</volume>, <fpage>366</fpage>&#x02013;<lpage>377</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.21423</pub-id><pub-id pub-id-type="pmid">18330886</pub-id></citation></ref>
<ref id="B14">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marillonnet</surname> <given-names>S.</given-names></name> <name><surname>Thoeringer</surname> <given-names>C.</given-names></name> <name><surname>Kandzia</surname> <given-names>R.</given-names></name> <name><surname>Klimyuk</surname> <given-names>V.</given-names></name> <name><surname>Gleba</surname> <given-names>Y.</given-names></name></person-group> (<year>2005</year>). <article-title>Systemic <italic>Agrobacterium tumefaciens</italic>&#x02013;mediated transfection of viral replicons for efficient transient expression in plants</article-title>. <source>Nat. Biotechnol.</source> <volume>23</volume>, <fpage>718</fpage>&#x02013;<lpage>723</lpage>. <pub-id pub-id-type="doi">10.1038/nbt1094</pub-id><pub-id pub-id-type="pmid">15883585</pub-id></citation></ref>
<ref id="B15">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neupert</surname> <given-names>J.</given-names></name> <name><surname>Karcher</surname> <given-names>D.</given-names></name> <name><surname>Bock</surname> <given-names>R.</given-names></name></person-group> (<year>2009</year>). <article-title>Generation of Chlamydomonas strains that efficiently express nuclear transgenes</article-title>. <source>Plant J.</source> <volume>57</volume>, <fpage>1140</fpage>&#x02013;<lpage>1150</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-313X.2008.03746.x</pub-id><pub-id pub-id-type="pmid">19036032</pub-id></citation></ref>
<ref id="B16">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Orellana-Escobedo</surname> <given-names>L.</given-names></name> <name><surname>Rosales-Mendoza</surname> <given-names>S.</given-names></name> <name><surname>Romero-Maldonado</surname> <given-names>A.</given-names></name> <name><surname>Parsons</surname> <given-names>J.</given-names></name> <name><surname>Decker</surname> <given-names>E. L.</given-names></name> <name><surname>Monreal-Escalante</surname> <given-names>E.</given-names></name> <etal/></person-group>. (<year>2015</year>). <article-title>An Env-derived multi-epitope HIV chimeric protein produced in the moss Physcomitrella patens is immunogenic in mice</article-title>. <source>Plant Cell Rep.</source> <volume>34</volume>, <fpage>425</fpage>&#x02013;<lpage>433</lpage>. <pub-id pub-id-type="doi">10.1007/s00299-014-1720-6</pub-id><pub-id pub-id-type="pmid">25477207</pub-id></citation></ref>
<ref id="B17">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname> <given-names>L.</given-names></name> <name><surname>Ren</surname> <given-names>L. J.</given-names></name> <name><surname>Li</surname> <given-names>J.</given-names></name> <name><surname>Sun</surname> <given-names>G. N.</given-names></name> <name><surname>Sun</surname> <given-names>L. N.</given-names></name> <name><surname>Ji</surname> <given-names>X. J.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>Biomass composition, lipid characterization, and metabolic profile analysis of the fed-batch fermentation process of two different docosahexanoic acid producing <italic>Schizochytrium</italic> sp. strains</article-title>. <source>Appl. Biochem. Biotechnol.</source> <volume>171</volume>, <fpage>1865</fpage>&#x02013;<lpage>1876</lpage>. <pub-id pub-id-type="doi">10.1007/s12010-013-0456-z</pub-id><pub-id pub-id-type="pmid">24061873</pub-id></citation></ref>
<ref id="B18">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ramos-Martinez</surname> <given-names>E. M.</given-names></name> <name><surname>Fimognari</surname> <given-names>L.</given-names></name> <name><surname>Sakuragi</surname> <given-names>Y.</given-names></name></person-group> (<year>2017</year>). <article-title>High yield secretion of recombinant proteins from the microalga <italic>Chlamydomonas reinhardtii</italic></article-title>. <source>Plant Biotechnol. J.</source> [Epub ahead of print]. <pub-id pub-id-type="doi">10.1111/pbi.12710</pub-id><pub-id pub-id-type="pmid">28207991</pub-id></citation></ref>
<ref id="B19">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rasala</surname> <given-names>B. A.</given-names></name> <name><surname>Lee</surname> <given-names>P. A.</given-names></name> <name><surname>Shen</surname> <given-names>Z.</given-names></name> <name><surname>Briggs</surname> <given-names>S. P.</given-names></name> <name><surname>Mendez</surname> <given-names>M.</given-names></name> <name><surname>Mayfield</surname> <given-names>S. P.</given-names></name></person-group> (<year>2012</year>). <article-title>Robust expression and secretion of Xylanase1 in <italic>Chlamydomonas reinhardtii</italic> by fusion to a selection gene and processing with the FMDV 2A peptide</article-title>. <source>PLoS ONE</source> <volume>7</volume>:<fpage>e43349</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0043349</pub-id><pub-id pub-id-type="pmid">22937037</pub-id></citation></ref>
<ref id="B20">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>R&#x000ED;os-Huerta</surname> <given-names>R.</given-names></name> <name><surname>Monreal-Escalante</surname> <given-names>E.</given-names></name> <name><surname>Govea-Alonso</surname> <given-names>D. O.</given-names></name> <name><surname>Angulo</surname> <given-names>C.</given-names></name> <name><surname>Rosales-Mendoza</surname> <given-names>S.</given-names></name></person-group> (<year>2017</year>). <article-title>Expression of an immunogenic LTB-based chimeric protein targeting <italic>Z. ebolavirus</italic> epitopes from GP1 in plant cells</article-title>. <source>Plant Cell Rep.</source> <volume>36</volume>, <fpage>355</fpage>&#x02013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1007/s00299-016-2088-6</pub-id></citation></ref>
<ref id="B21">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Rosales-Mendoza</surname> <given-names>S.</given-names></name></person-group> (ed.). (<year>2016a</year>). <article-title>Perspectives for the algae-made biopharmaceuticals field</article-title>, in <source>Algae-Based Biopharmaceuticals</source> (<publisher-name>Springer</publisher-name>), <fpage>143</fpage>&#x02013;<lpage>158</lpage>.</citation></ref>
<ref id="B22">
<citation citation-type="book"><person-group person-group-type="author"><name><surname>Rosales-Mendoza</surname> <given-names>S.</given-names></name></person-group> (ed.). (<year>2016b</year>). <article-title>Genetic engineering approaches for algae</article-title>, in <source>Algae-Based Biopharmaceuticals</source> (<publisher-name>Springer</publisher-name>), <fpage>15</fpage>&#x02013;<lpage>40</lpage>.</citation></ref>
<ref id="B23">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salazar-Gonz&#x000E1;lez</surname> <given-names>J. A.</given-names></name> <name><surname>Ba-uelos-Hern&#x000E1;ndez</surname> <given-names>B.</given-names></name> <name><surname>Rosales-Mendoza</surname> <given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Current status of viral expression systems in plants and perspectives for oral vaccines development</article-title>. <source>Plant Mol. Biol.</source> <volume>87</volume>, <fpage>203</fpage>&#x02013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1007/s11103-014-0279-5</pub-id><pub-id pub-id-type="pmid">25560432</pub-id></citation></ref>
<ref id="B24">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scranton</surname> <given-names>M. A.</given-names></name> <name><surname>Ostrand</surname> <given-names>J. T.</given-names></name> <name><surname>Fields</surname> <given-names>F. J.</given-names></name> <name><surname>Mayfield</surname> <given-names>S. P.</given-names></name></person-group> (<year>2015</year>). <article-title>Chlamydomonas as a model for biofuels and bio-products production</article-title>. <source>Plant J.</source> <volume>82</volume>, <fpage>523</fpage>&#x02013;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1111/tpj.12780</pub-id><pub-id pub-id-type="pmid">25641390</pub-id></citation></ref>
<ref id="B25">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Scranton</surname> <given-names>M. A.</given-names></name> <name><surname>Ostrand</surname> <given-names>J. T.</given-names></name> <name><surname>Georgianna</surname> <given-names>D. R.</given-names></name> <name><surname>Lofgren</surname> <given-names>S. M.</given-names></name> <name><surname>Li</surname> <given-names>D.</given-names></name> <name><surname>Ellis</surname> <given-names>R. C.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>Synthetic promoters capable of driving robust nuclear gene expression in the green alga <italic>Chlamydomonas reinhardtii</italic></article-title>. <source>Algal Res.</source> <volume>15</volume>, <fpage>135</fpage>&#x02013;<lpage>142</lpage>. <pub-id pub-id-type="doi">10.1016/j.algal.2016.02.011</pub-id></citation></ref>
<ref id="B26">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>X.</given-names></name> <name><surname>Zang</surname> <given-names>X.</given-names></name> <name><surname>Zhang</surname> <given-names>X.</given-names></name></person-group> (<year>2015</year>). <article-title>Production of high docosahexaenoic acid by <italic>Schizochytrium</italic> sp. using low-cost raw materials from food industry</article-title>. <source>J. Oleo. Sci.</source> <volume>64</volume>, <fpage>197</fpage>&#x02013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.5650/jos.ess14164</pub-id><pub-id pub-id-type="pmid">25748379</pub-id></citation></ref>
<ref id="B27">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sridhar</surname> <given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>Clinical development of Ebola vaccines</article-title>. <source>Ther. Adv. Vaccines</source> <volume>3</volume>, <fpage>125</fpage>&#x02013;<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1177/2051013615611017</pub-id><pub-id pub-id-type="pmid">26668751</pub-id></citation></ref>
<ref id="B28">
<citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>W.</given-names></name> <name><surname>Sack</surname> <given-names>D. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Current progress in developing subunit vaccines against enterotoxigenic <italic>Escherichia coli</italic>-associated diarrhea</article-title>. <source>Clin. Vaccine Immunol.</source> <volume>22</volume>, <fpage>983</fpage>&#x02013;<lpage>991</lpage>. <pub-id pub-id-type="doi">10.1128/CVI.00224-15</pub-id><pub-id pub-id-type="pmid">26135975</pub-id></citation></ref>
</ref-list>
<fn-group>
<fn fn-type="financial-disclosure"><p><bold>Funding.</bold> Current investigations from the group are supported by CONACYT/M&#x000E9;xico (grant INFR-2016-271182 and CB-256063 to SR and PDCPN2014-01/248033 to CA). Patent in process.</p>
</fn>
</fn-group>
</back>
</article>